MedTrace Logo

Histologic Response to UVA and UVB Exposure During the Use of Sunscreen

NCT01892150 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2014-03-31

No results posted yet for this study

Summary

Anti-inflammatory and anti-oxidant agents have become the important ingredients in sunscreen. However, there is no histologic study about the effects of anti-inflammatory and anti-oxidative properties of sunscreen to prevent premature aging from UVA and UVB.

Conditions

  • Solar Elastosis

Interventions

OTHER

Sunscreen

Apply sunscreen before and after UVA and UVB irradiation

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Rungsima Wanitphakdeedecha, MD, MA, MSc · Mahidol University

Study Design

Allocation
NA
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01892150 on ClinicalTrials.gov